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ABSTRACT 
Since 1973, patients with advanced tumors (Stage 
III and IV) of the pyriform sinus and hypopharynx 
have been consistently treated with surgery and 
postoperative radiation therapy by the Yale Section 
of Otolaryngology. This study will investigate 
whether this form of combined therapy provides more 
patients with longer disease-free survival than 
preoperative radiation therapy and surgery which 
patients received prior to 1973. Charts of 86 
patients with advanced tumors of the pyriform sinus 
and hypopharynx treated by the Yale Section of 
Otolaryngology with combination therapy between 
January 1963 and December 1984 were reviewed. 
Fifty-nine patients were included in the study. 
The results of this review showed a 45 percent 
two-year and a 24 percent five-year disease-free 
i i i 

survival among patients receiving preoperative 
radiation therapy. In the preoperative radiation 
therapy group, there were two perioperative deaths 
due to carotid rupture. Other treatment 
complications included fistula formation, abscess, 
and pulmonary infiltrate. In the surgery and 
postoperative radiation therapy group, there was a 37 
percent two-year disease-free survival and a 17 
percent five-year disease-free survival. 
The difference in survival between the two 
treatment groups did not achieve significance using 
the chi-square test. These results agree with the 
results published in the literature which show no 
consistent advantage for either mode of combination 
therapy. These data show postoperative radiation 
therapy provides little hope for increasing 
disease-free survival over preoperative radiation 
therapy, although it is technically more practical 
providing a better surgical field with fewer 
perioperative mortalities. 
i v 

INTRODUCTION 
The pyriform sinuses (aka pyriform fossa or 
recesses) are located adjacent to the glottis and 
behind the thyroid cartilage ala. They are the 
recesses through which solids and liquids are 
channeled into the esophagus. The 1980 American 
Joint Committee on Cancer (AJC) places the pyriform 
sinus in the region of the hypopharynx, which 
includes the pyriform sinus, posterior cricoid area 
( p o st c r i c o id ) and posterior hypophary ngeal wall.'*' 
Each pyriform sinus is shaped like an inverted horn 
or pyramid, as described in a recent article by T. 
Sasaki: 
The pyriform sinus or recess (is) defined as 
the space which extends from the 
pharyngoepiglottic fold (superiorly), to the 
entrance of the esophagus (interiorly). 
Laterally, the sinus is bounded by the inner 
aspect of the thyroid cartilage and medially 
is bounded by the arytenoepiglottic fold and 
mouth of the esophagus.^ 
Anatomically this is a very confined region which 
is difficult to assess on physical examination or by 
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clinical inspection in the clinic. The apex of the 
pyriform sinus is subject to thorough indirect mirror 
examination only by the most skillful of examiners. 
The walls of the pyriform sinus are often only 
partially open when viewed from above. Direct 
laryngoscopy performed under general anesthesia could 
provide information on the horizontal extent of 
tumor, but is unable to accurately ascertain the 
extent of submucosal infiltration or soft tissue 
invasion. 
Radiologically, contrast laryngography had been 
the diagnostic procedure of choice in the 1960s. 
Contrast laryngography was unable to provide 
information to evaluate the extent of tumor 
invasion. In the 1970s, Computed Axial Tomography 
(CT-Scan) was shown to be a superior method of 
radiologic evaluation, able to accurately determine 
the vertical extent of tumor and the degree and 
presence of cervical adenopathy. Cartilagenous 
invasion can be detected, although it can be 
difficult to accurately determine due to irregular 
ossification of the laryngeal framework. 
Ossification of the cartilagenous framework can be 
mistaken for tumor invasion of cartilage on CT-Scan. 
Misleading results have also been found 
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using the CT-Scan to evaluate soft tissue invasion by 
tumor specifically, over estimation of tumor size due 
to associated edematous changes, inflammation, and 
4 — 6 
mass effect of tumor. Magnetic Resonance 
Imaging (MRI) utilizing surface coil technology seems 
to hold the promise of detailed studies of submucosal 
tissue and deep tissue planes in this region. MRI 
may improve the ability of the surgeon, in 
cooperation with the radiologist, to preoperatively 
assess the degree of tumor extension and infiltration 
into the cartilagenous laryngeal framework and tumor 
4 — 6 
invasion of the soft tissues of the neck. 
On physical exam the loss of thyroid crepitations 
or fullness behind the thyrohyoid or cricohyoid 
membrane may be an indication of malignant disease 
which is already well advanced. Tumors in this 
region often do not produce symptoms until late in 
their course. By the time they become clinically 
apparent, they may have become quite large with 
extensive invasion and infiltration. One-third of 
patients initially present with dysphagia secondary 
to mass obstruction. The ominous appearance of firm 
cervical nodes unresponsive to antibiotic therapy is 
the first clinical sign of malignancy in 20-25 
percent of patients. Vocal changes such as 
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hoarseness may occur late or not at all; "hot potatoe 
voice" may signify infiltration of the base of the 
tongue. Other late symptoms include weight loss, 
foul breath, and general disability.^ Recently the 
advent of flexible fiberoptic endoscopy of the 
oropharyngeal region has allowed for improved direct 
visualization of the region with a permanent record 
made on video tape. This technological innovation 
may permit earlier diagnosis of these tumors. 
The advanced stage of these tumors at 
presentation has historically lead to a very dismal 
prognosis. Mattox (1985) in a review article 
reported that 60-75% of hypopharyngeal tumors occur 
in the pyriform sinus and most published series 
report 20-30 percent five-year survival. Nodal 
metastases reduce survival by one-half and are 
present in 50-80 percent of cases of hypopharyngea1 
carcinoma, although 25 percent of the time they are 
clinically occult.^ 
Sites of tumor origin in the pyriform sinus 
include the apex, medial wall, lateral wall and 
g 
aryepiglottic fold. 

EMBRYOLOGY AND ANATOMY OF THE HYPOPHARYNX 
The structures of the pharyngeal region arise 
from the branchial arches and clefts whose most 
active development takes place between the fourth and 
twelfth weeks of gestation. The laryngotracheal 
ridge appears during the fourth week caudal to the 
fourth pharyngeal pouch. Furrows develop on either 
side of this ridge which progressively deepen and 
eventually join to form the laryngotracheal tube. 
The cranial end of this tube forms the primitive 
laryngeal aditus (slit) (Figure 1). Hast describes 
the development of the laryngeal region between the 
fourth and fifth pharyngeal arches. 
The vocal folds and thyroarytenoid muscle 
are not differentiated until the mesenchymal 
mass of cells that forms the future glottis 
has split and the ventrodorsal depth of the 
thyroid cartilage has increased. With the 
development of the thyroid cartilage during 
the second month, the vocal folds are drawn 
out between the intra thyroid lamina and the 
arytenoid cartilages. The normal formation 
of the vocal folds, however, is intimately 
related to the development of the sinus of 
the larynx and the vestibular folds. During 

Tongue 
P /; F 
* Development of the embryonic larynx and at birth: (.4) 4 weeks (5 mm) 
{B) 5 weeks <9 mm>: (O 6 *eeks (12 mm); ( D) 7 weeks (16 mmi; (E) 10 weeks 
(40 mm); (F) at birth. (From Arey, 1965.) 
Figure 1, From Hinchliffe, Ronald ands Harrison, Donald (eds. 
Scientific Foundations of Otolaryngology, 
William Heinemann Medical Books, 1976 
p.531 

6 
this period there is an outpouching of the 
lateral and inferior portion of the 
laryngeal cavity, extending from the 
eminence of the arytenoid anteriorly to the 
floor of the primitive vestibule. The apex 
of this evagination forms the saccule of the 
larynx and the proximal and wider portion of 
the sinus of the larynx. With the 
development of the sinuses (between the 
fourth and fifth arches), the vocal and 
vestibular folds are separated, the mass 
splitting during the third month 
(Hinchcliffe and Harrison).^ 
Krahl (1950) described the development of the 
branchial arches and pouches. He illustrates the 
interaction of the third branchial arch with its 
branchial cleft and the formation of the parathyroid 
gland (P III) with its subsequent separation and 
migration from its pharyngeal opening (Figure 2). 
"The pyriform fossa at either side of the laryngeal 
opening marks the original location of the third 
pouch. The site of the fourth pharyngeal pouch is 
less distinct . . . it is at the lower end of the 
pharynx . . . somewhat dorsal to the third pouch, 
being separated from the latter by the fold of the 
i i ..10 laryngeal nerve. 
In the adult, this region is called the 
hypopharynx. Donald (1984) describes the pyriform 
sinus of the hypopharynx in detail: 
The hypopharynx includes both pyriform 
fossae and an intervening area of the 
pharynx directly posterior to the larynx; 
the anteror wall of this area is called the 
postcricoid area. Each pyriform fossa is 

^ — . Schema of the morphogenesis of the third branchial pouch and its derivatives, seen from ventral. 
A. Third branchial pouch approaching the floor of branchial cleft III. 
B. Elongation of third pouch into the primordium of the thymus. Early association of the cervical sinus with 
the thymus. 
C. Appearance of the primordium of parathyroid III at the cephalic end of the pharyngeal pouch. Separation 
of ectodermal sinus; its dorsal relationship to the upper end of the thymus. 
D. Complete separation of third pouch derivatives from the pharynx. 
E. Growth of parathyroid III, and elongation of the thymus; beginning of isolation of third branchial complex 
components. 
F. Caudal migration of thymus. B.C., III, Branchial cleft III. C.S., Cervical sinus. E P. Ill, Third entodermal 
pharyngeal pouch. E.Th., Entodermal thymus. P. III. Parathyroid III. P.D., Pharyngo-branchial duct. Ph., 
Pharynx. R.P.D., Remnant of pharyngo-branchial duct. Th., Thymus. (Redrawn from illustrations by E. Erickson 
n article by Norris, ’37. Courtesy, Carnegie Institution of Washington.) 
Ward, Grant and Hendrick, James 
Diagnosis and Treatment of Tumors fo the Head and 
Neck, Williams and Wilkins, 1950 p.59 
Figure 2 
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rimmed by the aryepiglottic fold medially, 
the lateral pharyngoepiglottic fold 
anterolaterally, and the lateral 
hypopharyngeal wall lateroposteriorly. The 
aryepiglottic fold is considered to be the 
medial wall of the pyriform sinus. This 
fold is actually part of the larynx, but the 
medial wall of the pyriform sinus begins 1 
cm below the fold's superior most 
extremity. This medial wall pyriform mucosa 
is in continuity with that of its opposing 
side through the aforementioned postcricoid 
area. The cricoid cartilage is the 
principal skeletal component supporting this 
latter region. The posterior cricoarytenoid 
muscles and a portion of the interarytenoid 
muscles intervene between the mucosa and the 
cartilage. At the inferior border of the 
cricoid, the hypopharynx becomes the 
cervical esophagus. 
The posterior wall of the pharyngeal area is 
continuous with that of the oropharynx above 
and the cervical esophagus below. 
The pyriform fossae, except at their 
posterior extremities, are contained within 
the alae of the thyroid cartilage: 
Superiorly, the aryepiglottic and, slightly 
more inferiorly, the lateral cricoarytenoid 
muscles separate the fossae from the 
laryngeal lumen. The arytenoid cartilage 
composes part of this medial wall 
posteriorly. Inferiorly, the cricoid 
cartilage makes up this wall as the pyriform 
progressed toward the cervical esophagus 
(Donald, p. 63-54, Figure 3).H 
From this description the intimate relationship 
of the pyriform sinus and hypopharynx to several 
important structures in the neck can be seen. These 
are the cervical opening of the esophagus, the 
laryngeal opening of the trachea, and the recurrent 
laryngeal branch of the vagus nerve. 

Inferior 
constrictor 
A 
Figure 3, Donald, Paul J. Head and Neck Cancer Management of 
Difficult Cases, W.B. Saunders, 1984 
p. 63 

8 
An important structure related to the 
pharyngeal wall in this region is the 
recurrent laryngeal nerve, which lies 
between the cricopharyngeus fibers of the 
inferior constrictor muscle of the pharynx 
and the posterior cricoarytenoid muscle of 
the larynx (MacComb and Fletcher).12 
Late stage tumors often involve adjoining 
structures. Involvement of the cervical chain of 
sympathetic nerves may produce a Horner's syndrome. 
The carotid sheaths which pass immediately outside 
the layer of constrictor muscles on either side of 
the neck may also be involved. Lesions in the 
hypopharynx may impinge on the internal branch of the 
superior laryngeal nerve leading to the symptom of 
ear pain. 
The muscle layers which surround the structures 
of the hypopharynx are continuous with those of the 
oropharynx above: 
The hypopharynx is composed of the middle 
and inferior constrictor muscles of the 
pharynx and their investing fascial layers. 
The loose areolar fascia between the 
buccopharyngeal fascia investing the 
muscular coats and the stout fascia of the 
prevertebral area exists in the same way 
that it does in the oropharynx . . . 
(Donald) 
The aggressive spread of carcinoma in this region 
is due, in part, to the lack of restricting anatomic 
barriers. Muscle tissue is relatively resistant to 
invasion. When tumor extends into the cartilagenous 
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framework of the larynx, it usually begins in the 
thyroid cartilage. Thyroid cartilage invasion 
13 
usually begins at the lateral border. 
The lymphatic network which drains the 
hypopharynx is extensive. The lymph nodes are 
intimately associated with the glandular, vascular 
and neural structures which pass through the region, 
and carry the same names. Specifically, lymph node 
chains are associated with the internal jugular vein, 
the spinal accessory nerve, the transverse cervical 
nerve, the parotid gland, the submaxillary gland, and 
the submandibular gland. 
The deep cervical lymph nodes are clinically 
important, they receive the lymph from the mucous 
membranes which line the region. Their lymphatic 
channels have a larger caliber than superficial 
vessels which increases the rate and probability of 
metastatic tumor seeding. 
The most important of the deep cervical nodes are 
those which lie along the internal jugular vein. The 
most superior group are the primary echelon nodes. 
They lie just below the posterior belly of the 
digastric muscle. The most inferior group of jugular 
nodes lies just above the clavicle.^ This 
provides the anatomic basis for ligation and removal 
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of the internal jugular vein and its associated nodes 
in the standard radical neck dissection. 
Lymphatic chains also follow the course of the 
spinal accessory nerve beneath the upper end of the 
sternocleidomastoid muscle, running posteriorly and 
inferiorly into the posterior triangle. These nodes 
primarily drain the nasopharynx, but they communicate 
14 
with the internal jugular chain. Cervical 
lymphatics contain valves. Retrograde flow to 
collateral lymphatic vessels occurs after obstruction 
of main lymphatic channels by tumor. Involvement of 
spinal accessory nodes of the posterior triangle 
occurs when tumor cells are carried retrograde due to 
blockage of the jugular chain.^ The spinal 
accessory nerve may itself be involved with tumor and 
is sacrificed in the standard radical neck. 
Preservation of this nerve and the ipsilateral 
function of the trapezius muscle is a feature of the 
modified neck dissections discussed elsewhere in this 
paper. 
Tumors of the pyriform sinus and hypopharynx are 
often clinically silent in the early stages. The 
cancer spreads from the primary site along the 
pharyngeal mucosa, or submucosally via infiltration 
of soft tissue planes. Lesions which arise "on the 

11 
lateral walls spread upward and downward In the 
pharyngeal mucosa then laterally to invade the 
thyroid cartilage, the thyroid gland, and the 
cartilagenous structures of the neck. When the 
original site is on the medial wall, the growth 
extends upward and medially to invade the arytenoid 
and the aryepiglottic fold and eventually encroaches 
..12 
upon the vestibule of the larynx. 
Primary tumor spreads along the path of least 
resistance (fascial planes). Muscle tissue itself is 
relatively resistant to tumor invasion, as are bone 
and the cartilagenous framework of the larynx. 
Involvement of these structures indicates advanced 
, . 13 disea se. 
Perineural spread occurs along nerve bundles and 
should be suspected when patients complain of ear 
pain, localized burning, stinging, or shooting 
15 pa l n. 
Clinically, the symptoms associated with a mass 
obstruction in the hypopharynx includes obstruction 
of the airway (dyspnea), delay or obstruction of the 
passage of food in the esophagus (dysphagia), pain 
upon swallowing (odynophagia) and ear pain due to 
laryngeal nerve involvement (otalgia). Behavioral 
adaptation to these symptoms, especially decreased 
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appetite and food intake secondary to difficult or 
painful swallowing leads to the dramatic weight 
losses often seen at presentation. 
Other symptoms at presentation are caused by 
metastatic involvement of cervical lymph nodes of the 
neck ("mass in the neck"). Direct infiltration and 
extension along soft tissue planes can lead to 
"hoarseness" secondary to involvement of vocal cords 
or cricoarytenoid muscle. 
The superior laryngeal branch of the vagus nerve 
(cranial nerve 10), develops with the fourth 
pharyngeal arch. The internal branch of the superior 
laryngeal nerve supplies sensory innervation to the 
mucosa of the laryngopharynx and larynx down to the 
level of the true vocal cord. The external branch of 
the superior laryngeal nerve provides motor 
innervation to the cricothyroid muscle. 
The inferior laryngeal branch of the vagus nerve 
is called the recurrent nerve. It supplies all the 
intrinsic muscles of the larynx, the inferior 
constrictor muscle, the upper fibers of the 
esophagus, and the mucous membrane of the larynx, 
below the level of the true cord. In the adult, the 
internal branch of the superior laryngeal nerves (4th 
pharyngeal arch) lies on the thyrohyoid membrane 
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between the greater cornu of the hyoid bone and the 
upper margin of the thyroid cartilage. The inferior 
(recurrent) laryngeal nerve (6th pharyngeal arch) 
runs in the tracheoesophageal groove and enters the 
larynx posterior to the cricothyroid joint under the 
thyroid cartilage. 
The symptom of ear pain (otalgia), occurs 
unilaterally on the same side as the lesion and is 
mediated by tumor involvement with the superior 
laryngeal nerve of the vagus nerve. The vagus nerve 
innervates the external ear canal via the auricular 
nerve (Arnold's nerve). It also innervates the 
hypopharynx via the interna1 branch of the superior 
laryngeal nerve. This internal branch becomes 
involved with tumor or regions of mucosal ulceration 
in some cases of advanced disease. Synapses in the 
jugular ganglion (pharyngeal plexus), provide the 
pathway for referred pain felt in the ear (Figure 
It has been well documented in the medical 
literature that, for tumors of the hypopharynx, the 
clinical appearance of these symptoms indicate 
advanced stage disease (Stage III or Stage IV). 
Similar symptoms may occur with tumors of adjoining 
regions, but are associated with an earlier stage of 

Fio. 7.4. Nerve paths by which an ulcerated lesion in the hypopharynx produces pain 
in the ear. 
Figure 4: Donald, Paul J. Head and Neck Cancer Management 
of Difficult Cases, W. B. Saunders, 1984 p 223 
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disease. This is largely because the extensive 
lymphatic network of the hypopharynx (described 
elsewhere) leads to tumor cell seeding of lymph nodes 
early in the development of tumors in the pyriform 
sinus and hypopharynx. The tonsillar region, and 
floor of mouth are also richly enmeshed with 
lymphatic vessels and, like hypopharyngeal tumors, 
may first present with lymph node enlargement. 
Martin (1950) established the principle that 
"Enlargement of Lymph Nodes Demands a Search for the 
Primary Growth of Cancer. Martin describes the 
characteristics of those anatomic regions in the head 
and neck which lead to clinical presentation with 
advanced stage disease: 
1 - function not affected by the presence of 
small or moderate sized growths 
2 - a meager sensory nerve supply 
3 - a relatively high proportion of primary 
cancer occuring at the given anatomic 
site 
4 - the relative and absolute frequency of 
metastasis from growths at the given 
site 
5 - the relative inaccessibility of the given 
anatomic site to physical examination. 
Martin further noted that the anatomy of the cervical 
lymphatics has uniform and constant features. He 
goes on to state: 
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Main lymph channels are always present at 
the same location; e.g., the internal 
jugular chain, the spinal accessory chain, 
the submaxillary and submental node groups, 
etc. These lymph nodes and lymph node 
groups always receive the main lymph 
drainage from relatively specific anatomic 
areas although there is some overlapping and 
no distinct line of demarcation . . . 
(Martin and Morfit).-*-^ 
The constant relationship between lymph node groups 
and the anatomic regions they drain allows an 
examiner to suspect a primary tumor in a specific 
site when a patient presents with a clinically 
palpable node in the neck (Figure 5). 
Lymphatic spread of tumor occurs by embolization, 
but does not follow a predictable pattern along the 
lymphatic chain. Skip metastases are frequently 
seen. Primary echelon drainage from most tumor sites 
in the mouth and throat is to the upper deep jugular 
chain (subdigastric nodes, jugulocartoid nodes). 
Lymphatics from the pyriform sinus drain through the 
thyrohyoid membrane to jugulodigastric and midjugular 
nodes. Clinical involvement of these nodes increases 
the probability of lower level and contralateral neck 
disease. If primary echelon nodes are not involved, 
it is dangerous to assume that lower nodes are free 
* , . 14 
of disease. 
Lesions of the pyriform sinus usually present 
with unilateral node disease, although subsequent 

igure 5, 
Rarely involved early 7' 
except from cancer of lip 
Anterior Vj of loncj 
mouth, cjums, mucosa of chee 
Nasopharynx 
Any portion of oral 
cavity, pharynx or larynx 
- (Especially qrowths in 
Waldeyers ring-naso¬ 
pharynx, tonsil, base 
of tonque.) 
Nasopharynx 
Same as but early involve 
ment less frequent 
5 Thyroid, pyriform sinuses, upper 
esophagus.rarely from primary 
below clavicle 
Various lymph node groups with the most likely sites of the primary lesions 
which may cause the metastases. 
Martin, Hayes and Morfit, Mason. "Cervical Lymph Node 
Metastasis as the First Symptom of Cancer" 
Surg Gynecol & Obstet 78:133, 1944 
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contralateral metastatic nodes may develop in up to 
30 percent of cases.^ Bilateral nodes at 
presentation usually occur with primary tumors at the 
midline or where lymphatic drainage is bilateral such 
as the posterior pharyngeal wall. This is the site 
of origin of 10-20 percent of hypopharyngeal 
15 
tumors. 
The history of treatment protocols for tumor of 
the pyriform sinus and hypopharynx is well documented 
in the surgical literature and the radiation therapy 
literature. Tumors in this region do not present 
clinically until they are well advanced. Patients 
usually come to the clinic with Stage III or Stage IV 
disease and often with metastatic disease to the 
lymph nodes of the neck. Poor therapeutic outcomes 
(10-30 percent two-year survival with single modality 
therapy) led to efforts with combination radiation 
therapy and surgery. 
Adjuvant chemotherapy has been attempted but the 
results have not been encouraging and chemotherapy 
has played a minor role in treatment of these tumors. 
Some large patient series presented in the 
literature include patients with tumors in all head 
and neck regions. These tumors are primarily 
squamous cell carcinomas and are treated with the 
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same types of therapy as those in the hypopharynx. 
These reports are included because they usually 
represent the largest number of patients and provide 
significant outcome data. 
Theoretically combination therapy improves 
patient prognosis because surgery and radiation 
therapy act to destroy or eliminate the malignancy in 
different ways. Surgery removes the primary tumor, 
eliminating a focus for tumor spread which occurs via 
direct extension into surrounding tissues or by the 
primary site acting as a nidus for metastatic tumor 
seeding presumably via lymphatic or hematologic 
circulation. Radiation therapy preferentially 
damages malignant cells preventing their growth and 
reproduction. 
The hypopharynx of many of these patients has 
been chronically exposed to carcinogens and 
co-carcinogenic agents (especially ethanol and 
18 
tobacco). The regional mucosa develops 
metaplastic changes which increase the risk of 
malignancy. Whatever the mechanism of malignant 
transformation (e.g. breakdown of tumor immune 
surveillance), by convention the first clinically 
identified tumor site is called the primary tumor, 
although the entire mucosa remains at increased risk 
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for malignant transformation. Radiation therapy 
attempts to sterilize the "cancerized field" and use 
2 0 
additional rads to focus on known tumor sites. 
Tumor recurrence has been documented to occur 
rapidly in this region, 80-95 percent occur within 
15 21 22 
the first two years. * ’ Perhaps in some 
cases, these recurrent tumors represent independent 
cancer foci arising from this chronically insulted 
region. 
In the 1960s, preoperative radiation therapy and 
surgery was attempted at numerous centers. Radiation 
therapy was directed at shrinking the primary tumor 
to improve access for surgical excision and with the 
hope of sterilizing subclinical disease that may have 
existed in the lymph nodes of the neck. Radiation 
therapy doses were submaximal (<5,000 rads) to 
minimize radiation-induced tissue changes in the 
surgical field. Higher doses damage tissues leading 
to inflammation, necrosis, and fibrosis which would 
interfere with surgical planes as well as increase 
the friability of tissues and resultant risk of 
puncture wounds, especially to the carotid artery. 
Seven thousand rads is generally regarded as the 
maximum therapeutic radiation dose in the region. 
Some medical centers combined regionally specific 
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treatments, for example, radiation therapy to the 
primary tumor with a neck dissection, or surgery to 
the primary tumor with radiation therapy to the 
neck. Both surgery and radiation therapy were used 
as salvage therapy for failures of primary treatment 
with the other modality. Finally, surgical treatment 
of the primary with total laryngectomy and partial or 
total pharyngectomy and unilateral or bilateral neck 
dissection and postoperative radiation therapy 
received widespread trials in the 1970s as treatment 
became more aggressive. 
The literature is replete with reports on the 
results of these experiences. A selection from the 
recent literature is reviewed here. End results data 
reported by various authors support different 
conclusions regarding optimal treatment strategies. 
Each conclusion is usually supported by results 
presented by several different authors. The few 
prospective studies in the literature will be 
discussed separately in the appropriate sections. 

REVIEW OF LITERATURE 
t_Pre se nt at i o n 
Tumors of the hypopharynx are staged based on the 
classification of the 1980 American Joint Committee 
on Cancer Staging (AJC). These criteria have been 
revised periodically (1971, 1976). The essential 
elements of T stage, tumor size and fixation have 
remained consistent (e.g. T3 represents tumor 
extension with laryngeal fixation). Tumors are 
staged based on groupings of the TNM (primary Tumor, 
Nodal disease, distant Metastasis) classification 
shown below. Patient charts reviewed in this study 
are reported as they were staged by the authors. 
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Primary_Tumor_Staging 
TIS Carcinoma in situ 
T1 Tumor confined to site of 
origin 
T2 Extension of tumor to 
adjacent region without 
fixation of hemilarynx 
T3 Extension of tumor to 
adjacent region or site 
with fixation of hemi¬ 
larynx 
T4 Massive tumor invading 
bone or soft tissues of 
the neck 
The AJC recommends the actual size of the nodal 
mass be measured. Most masses over 3 centimeters in 
diameter are not single nodes, but confluent nodes or 
tumor in soft tissues of the neck. There are three 
stages of clinically positive nodes: Nl, N2, N3. 
Subgroup notations are recommended but not required. 
Midline nodes are considered homolateral nodes. Most 
authors use these staging criteria (listed below), or 
an abbreviated version. 
Nx Nodes cannot be assessed 
No No clinically positive node 
Nl Single clinically positive homolateral 
node 3 cm or less in diameter 
N2 Single clinically positive homolateral 
node more than 3 cm but not more than 
6 cm in diameter or multiple 
clinically positive homolateral nodes, 
none more than 6 cm in diameter 
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N2a Single clinically positive homolateral 
node more than 3 cm but not more than 
6 cm in diameter 
N2b Multiple clinically positive 
homolateral nodes, none more than 6 cm 
in diameter 
N3 Massive homolateral node(s), bilateral 
nodes or contralateral node(s) 
N3a Clinically positive homolateral 
node(s), one more than 6 cm in 
diameter 
N3b Bilateral clinically positive 
nodes (in this situation, each side 
of the neck should be staged separately) 
Nc Contralateral clinically positive 
node(s) only. 
Distant metastases are staged by their presence (Ml) 
or (MO). 
Stage grouping of patients is as follows: 
Stage I T1 NO MO 
Stage II T 2 NO MO 
Stage III T 3 NO MO 
T1 o r T2 or T3 N1 MO 
Stage IV T 4 NO or N1 MO 
Any T with N2 or N3 MO 
Any T with any N and Ml* 
*The presence of any distant metastasis makes a 
patient Stage IV. 
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Treatment of_P rimary_Tumor_with_Radiation 
Ionizing radiation preferentially damages 
proliferating cells. Cancer, by definition, is the 
unregulated growth of cells which exceed their own 
natural boundaries and invade continguous regions as 
well as embolize via lymphatic or hematologic 
circulation to distant areas. 
Radiation damages a cell either through 
ionization (ejection of an electron), or excitation 
(putting an electron in a different orbit in the same 
molecule). 
Damage may be the direct result of an 
ionization somewhere within a critical 
molecule such as DNA or it may be due to the 
indirect action of excited molecules which 
can diffuse for several seconds before 
reacting chemically with a critical 
molecule. It is the indirect portion of 
radiation injury which can be altered by 
radiosensitizing drugs including oxygen or 
by large changes in dose rate. Proteins and 
enzymes in the cell are less damaged by 
radiation than DNA, RNA or membranes. The 
result is that proliferation is the most 
radiosensitive function of the cell ... A 
cell which has been lethally damaged by 
irradiation does not break up and disappear 
at once. It usually does so at the next 
cell division or even at the second or third 
attempt . . . 
In the treatment of tumors the desired 
result is the killing, in the sense of 
prevention of proliferation, of all 
malignant cells. In normal tissues the main 
effects of radiation injury are also due, 
directly or indirectly, to the prevention of 
cell replacement (Hinchcliffe and Harrison, 
p. 735-736).8 

Malignant cells are preferentially affected because 
their reproduction is not regulated by factors which 
maintain normal cells within their histologic and 
anatomic boundaries. Cancer cells constantly 
reproduce at a faster rate than normal cells and are, 
therefore, more sensitive to radiation damage. 
Cell oxygenation also affect the efficacy of 
radiation therapy. Tumor cells quickly outgrow their 
vascular supply. The maximum diffusion range of 
oxygen is 150 micrometers, beyond this point necrotic 
foci appear. Hypoxic cells are intrinsically more 
resistant to ionizing radiation than well oxygenated 
ones. This is known as the "oxygen effect." 
Delivery of the radiation in fractional doses allows 
for greater oxygenation of those regions of tumor 
which survived the previous dose of radiation. Drugs 
which mimic the radiosensitizing effects of oxygen 
with minimal toxic side-effects have been developed 
for experimental use. These are called 
9 
radiosensitizers (p. 748). 
Radiation therapy has been used to treat primary 
tumor as well as metastatic disease in the neck. It 
seldom controls fixed nodes, or nodes greater than 3 
centimeters in diameter. 
Ionizing radiation has been used therapeutically 
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to destroy malignant cells in clinically positive 
nodes. It has also been used very successfully to 
sterilize subclinical microscopic tumor deposits and 
prevent the development of overt clinical disease. 
The effect of radiation on lymph nodes is 
dependent on the rate of cellular proliferation, and 
the total dose of radiation (rads) delivered. Up to 
3,000 rads, there is a reduction in the number of 
lymphocytes and some shrinkage of follicles. As the 
dose increases follicles are destroyed. At 4,000 
rads, no recognizable lymphoid tissue is seen and 
small lymphocytes disappear. The final appearance 
following high-dose radiation therapy is an 
2 3 
unrecognizable and hyalinized lymph node (p. 235). 
The use of radiation therapy is associated with 
numerous reactions in the mucosa which also has a 
high rate of cell turnover. Mucosal reactions to 
radiation include edema, erythema, and desquamation. 
Prolonged edema following completion of radiation 
therapy may conceal residual carcinoma. Experience 
shows that negative biopsies do not exclude the 
possibility of recurrence.^ 
Local tumor recurrence usually presents as firm 
nodules in the axis of the surgical scar, surrounding 
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skin, or mucosa. Recurrence in the area of the 
tracheostomy stoma is ominous and can be related to 
the primary tumor or involved paratracheal 
lymphatics. Other common sites of local/regional 
tumor recurrence include: pharyngeal wall, 
contralateral lymph nodes, ipsilateral lymph nodes, 
2 4 
and the base of the skull. 
Clinical features of recurrent tumor include a 
mass in the neck and consequent dysphagia or 
odynophagia, shortness of breath due to restriction 
of the airway by tumor at the tracheostomy stoma or 
other level of the airway including the bronchi. The 
patient's terminal event is most often due to 
asphyxiation or starvation. Severe complications of 
radiation therapy include: necrosis, esophageal 
stenosis, tracheal stenosis, fibrosis, xerostomia, 
dehydration, dermatitis, tracheal fistula, 
respiratory obstruction secondary to edema, 
respiratory failure and hypothyroidism. It is 
difficult to distinguish changes such as edema and 
fibrosis of the epiglottis and pharyngeal walls from 
recurrent tumor, or more importantly to determine if 
nests of tumor cells are reproducing within these 
regions. 
The standard of evaluation for recurrent tumor is 
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endoscopy and biopsies in the region submitted for 
pathologic analysis. These may give negative results 
when the clinical course is highly suggestive of 
recurrent malignancy. Benign tissue changes induced 
by radiation therapy may persist after completion of 
therapy and be difficult to distinguish from an 
active malignant process. Sometimes several negative 
biopsy results preceed a positive one. In these 
situations a clinical determination of tumor 
recurrence may supercede a histologic one. Bahduhar 
reviewed 52 surgical specimens of patients who 
received "surgical salvage" after radiation therapy. 
Fifty of the 52 cases (96 percent) showed 
the presence of a residual tumor in their 
operative specimens . . . the persistence of 
oedema with or without fixation of the 
larynx after radiation is strongly 
indicative of a residual/recurrent tumour, 
and that biopsies may be unwarranted in such 
cases . . . Repeated negative biopsies do 
not exclude the presence of a tumour and in 
fact only delay subsequent treatment with 
total laryngectomy.^ 
Radiation therapy for treatment of hypopharyngeal 
tumors was first attempted in the 1920s. In 1938, 
Colledge noted that "the results are neither so good 
that the method can claim to supplant simple surgical 
treatment, altogether, nor so bad they can be 
..12 dismissed as negligible." Patient series have 
consistently reported five-year survivals in the 
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range of 10-15 percent (p. 2339). 
Radiation therapy as the single mode of therapy 
for tumors of the hypopharynx and pyriform sinus has 
been in use for decades without appreciable 
improvement in survival rates. Lederman in 1962 
reviewed 734 patients with tumors of the 
laryngopharynx from 1933-1959 treated with radiation 
therapy. His data shows remarkable consistency of 
patient presentation and treatment results. Stage 
III and Stage IV tumors comprised 79 percent of 
patients at presentation. Minimum radiation therapy 
doses were 5,000 rads, maximum dose was 7,000 rads. 
Three-year survival of patients with Stage III 
lesions was 20 percent, for stage IV lesions it was 
an abysmal 5 percent. He advocated combination 
therapy be employed to attempt to improve survival 
25 rates. 
Byhardt (1980), presented 53 patients and 
reviewed the literature. He tabulated the results of 
six authors*, found a 21 percent three-year survival 
rate and an 11 percent five-year survival rate with 
radiation therapy alone. Recurrence at the primary 
site occurred 42 percent of the time, at cervical 
*Carpenter, 1976 ; Eisbach, 1977 ; Inove , 1973 ; 
Kirchner, 1977; Lord, 1973; Sagerman, 1979. 
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lymph nodes 76 percent of the time, and at distant 
2 6 
metastasis 11 percent of the time. 
Recent authors of consecutive series comparing 
radiation therapy with preoperative radiation therapy 
27-29 
followed by surgery , have found 44 percent, 61 
percent, and 72 percent two-year recurrence rates 
(site of recurrence not consistently specified) with 
patients in the radiation therapy alone arm of the 
study. 
Million in 1981 reported on 42 patients treated 
with radiation therapy alone. His sample consisted 
of patients referred for primary radiation therapy, 
after consultation with an otolaryngologist, unlike 
the consecutive patient series reported above and 
elsewhere in this paper. Sixty-two percent presented 
with T1 and T2 lesions with two-year and five-year 
NED survivals of 83 percent and 66 percent. Bias in 
his patient selection led to a skewed patient sample 
with a high percent of early lesions. There were 
sixteen T3 and T4 patients for 38 percent of the 
sample. The two-year absolute survival for Stage III 
was 62 percent and, for Stage IV, 52 percent. The 
five-year absolute survival was 38 percent for Stage 
3 0 III and 10 percent for Stage IV. 
Ahmad (1984) reported on an experience with 61 
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patients receiving high-dose radiation therapy alone 
with 68.8 percent (42/61) recurrence rate with a 2.5 
year minimum follow-up. This included a 60.6 percent 
(20/33) recurrence of T3 tumors and 100 percent 
2 7 (14/14) recurrence of T4 lesions at two years. 
In summary, radiation therapy as the sole 
treatment modality has fairly good curative potential 
in early lesions Stage I and Stage II, however, 
three-fourths of patients will present with advanced 
Stage III and Stage IV disease. Two-year survival 
for Stage III was 20 percent and for Stage IV 10 
percent or less. Two-year recurrence rates were as 
high as 72 percent. The maximal dose of radiation 
therapy has been determined to be 7,000 rads. 
Efforts to improve results of radiation therapy alone 
have consisted mainly of adjusting the radiation 
portals to include the neck nodes and the use of 
31 
radiosensitizing drugs. 
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Treatment of P£iraary_Tumor_with_Surgery 
Surgical treatment alone attempts to excise all 
evidence of gross tumor of the primary site and in 
cervical lymph nodes. Surgical techniques employed 
include total laryngectomy with total or partial 
pharyngectomy and supraglottic partial laryngectomy 
for early lesions not involving the apex of the 
sinus. Usually a unilateral or bilateral neck 
dissection was employed, yet as surgeons began making 
efforts to preserve function and improve cosmetic 
results the modified neck dissection was devised 
which preserves the spinal accessory nerve, internal 
jugular vein, and sternocleidomastoid muscle. More 
recently, efforts at cosmesis have led to increased 
efforts at tailoring the neck dissection to 
clinically involved lymph nodes and continguous nodal 
groups. Surgical treatment of metastatic disease in 
the neck is discussed at length in another section. 
Byhardt in his compilation of data on surgical 
treatment alone from the published work of eleven 
authors* reports incidence of local and regional 
*Byhardt compiled these figures from authors listed 
below, not all of whom are referenced in this study. 
Barton - 1973 Harwick - 1975 McGarvan - 1963 
Bryce - 1971 Inoue - 1973 Ogura - 1970 
Carpenter - 1976 Jesse - 1975 Shah - 1976 
Eisbach - 1977 Kirchner - 1977 
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recurrence is 84 percent and 70 percent respectively 
within two years, with distant metastasis occurring 
only 12 percent of the time. Disease-free survival 
rates were 42 percent at three years and 31 percent 
r • 29 
at five years. 
The data from a number of authors indicates there 
may be an important role for surgery alone in 
treatment of these tumors. Most recently, Yates 
reported a 65 percent determinate survival at three 
years and a 56 percent determinate survival at five 
3 2 years. These results agree with Eisbach who 
reported a 69 percent disease-free survival at three 
years and at five years in patients treated with 
3 3 
surgery alone. (Eisbach's results are included 
in Byhardt's summary.) Further analysis of Yates' 
results shows that 45 percent of his patients had 
Stage III or Stage IV disease. The survival data on 
this subgroup of patients with advanced tumors is 63 
percent at five years. Yates had noted a similar 
trend in surgically treated patients between 1959 and 
1976 in an unpublished review. 
Bahadur (1985) also reports better long-term 
results with surgery alone than with radiation 
therapy alone, or radiation therapy with surgical 
i 24 salvage. 
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Harrison (1970) presents a pathologic analysis of 
surgically managed cases which suggests that the 
ability of the surgeon to control recurrent disease 
may be determined at the primary site by the extent 
of submucosal invasion. His measurements showed the 
average submucosal extension of lesions in the 
pyriform sinus was 10mm and 5mm for tumors in the 
postcricoid region, and he emphasized the importance 
of a wide field of resection. He found that 
successful surgical control of neck disease was 
limited by the extent to which metastatic disease had 
34 
spread beyond the jugular chain of lymph nodes. 
Potential complications following surgery for 
cancer of the hypopharynx include wound infection, 
wound necrosis, salivary fistula, hemorrhage, and 
carotid catastrophe. 
Gall (1977) reviewed an eighteen-year experience 
at Washington University of St. Louis for rate and 
type of surgical complications. His most significant 
finding was that the only factor found to contribute 
to subsequent complications was the presence of 
margins positive for tumor in the surgical specimen. 
There was no variation in complication rate based on 
age, race, sex, site of primary, stage of tumor, or 
nodal fixation. An increased incidence of 
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complications was asssociated with an increased 
3 5 
incidence of fatality. 
Among patients with tumors of the hypopharynx 
receiving total laryngectomy the most common 
complication was carotid artery exposure and/or 
blowout (9.3 percent). Fistula formation occurred in 
seven percent of these patients. Patients treated 
with partial laryngopharyngectomy had wound sloughing 
as the most frequent complication (10.3 percent), 
with fistula formation occurring in 7.7 percent of 
35 
cases. 

Treatment of Cervical_Lymph_Nodej 
The anatomy and clinical presentation of patients 
with metastatic disease in the cervical lymph nodes 
has been discussed earlier in this paper. Clinically 
positive cervical nodes at presentation decrease 
survival by approximately 50 percent in patients with 
tumors of the hypopharynx. This region is a frequent 
site of treatment failure and data from the 
literature on regional or nodal recurrence have been 
discussed in another section also. This section will 
present treatment results for surgery, radiation 
therapy, and combined therapy in the neck 
specifically. There are numerous articles in the 
literature reporting on the treatment of neck disease 
in large series of patients with a variety of head 
and neck tumors. Some of these will be reviewed 
here. Where specific information is available on 
treatment of cervical metastasis of tumors of the 
pyriform sinus and hypopharynx it will be indicated. 
Treatment methods for nodal disease are the same 
as those for primary tumor surgery, radiation 
therapy, and combination therapy. The indications 
for each method and the extent to which radical 
measures are employed varies at different medical 
centers and over time. 
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Several authors have schematically grouped and 
identified the lymph nodes by anatomic region. The 
different locations have different clinical behavior, 
prognosis, and treatment (Figure 6a and 6b). 
The indications for surgery in the neck determine 
the treatment objective in performing the procedure. 
It is "therapeutic" when palpable nodal disease is 
present, "elective" when nodes are removed which 
contain microscopic tumor but are not clinically 
detectable, and "deferred” when previously unpalpable 
nodes develop into clinically positive metastasis. 
Treatment with radiation therapy is characterized as 
"therapeutic" when the goal is to control clinically 
positive nodes and "prophylactic" when the objective 
is to sterilize microscopic nests of tumor cells, (p. 
234) .23 
Surgical treatment of cervical lymph nodes is 
based on the standard radical neck dissection, first 
described by Crile in 1906. This procedure removes 
en bloc, lymph node bearing structures from the 
mandible to the clavicle and from the midline of the 
neck to the trapezius muscle, in their associated 
fascial envelopes. Modifications in this technique 
are described below. Hayes Martin in his 
comprehensive articles of the 1940s and I950s3^’3^ 
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popularized the radical neck dissection and 
articulated the principles for clinical evaluation 
and surgical intervention in metastatic disease to 
the cervical lymph nodes. 
The extent of the radical neck dissection 
sometimes included the parapharyngeal lymph nodes and 
retropharyngeal nodes of Rouviere. Structures 
important to daily functioning and cosmesis were 
removed including the spinal accessory, nerve 
(cranial nerve XI) leading to atrophy of the 
trapezius and shoulder droop which is painful in some 
patients. The sternoclediomastoid muscle is removed 
leading to a functional deficit and cosmetic 
deformity. The internal jugular vein is sacrificed 
without much impact in most patients due to 
collateral circulation. Morbidity associated with 
the radical neck dissection includes shoulder drop, 
skeletal pain, limitation of neck and limb motion, 
and cutaneous anesthesia of the region. 
In the 1960s, Bocca began tailoring neck 
dissections to remove the lymph nodes at highest risk 
for metastatic disease, preserving nerves, vessels, 
and muscles not grossly involved with tumor in an 
attempt to improve the functional and cosmetic 
results without sacrificing already modest control 
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and survival outcomes. This led to the development 
of the modified radical neck dissection or modified 
neck dissection. In the modified radical neck 
dissection, these three structures: spinal accessory 
nerve, sternocleidomastoid muscle, and internal 
jugular vein, are preserved if they are not involved 
grossly with tumor. The retropharyngeal lymph nodes 
are rarely dissected. "Modified neck dissections are 
conservative with respect to function, but radical 
with respect to cancer control."^ 
In the 1970s, other surgeons focused on this 
tailored approach and variations of the modified neck 
dissection were popularized. Variations of the 
modified neck dissection are described in Appendix A. 
"Preservation of the spinal accessory nerve 
(cranial nerve XI), a common feature of modified neck 
dissections should not be attempted when fixed nodal 
disease (N3) is present in the upper anterior 
cervical triangle, when metastatic posterior cervical 
nodes are present, or when the nerve is directly 
involved with cancer. 
Failure in the neck region is frequently 
associated with recurrence of tumor at the primary 
site. "Elective neck dissection for occult 
metastasis will control the neck for about one-half 
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of all patients. Deferred neck dissections only 
..2 3 
control about one-third of cases.” 
Patients with extracapsular nodal disease have been 
shown to have a higher recurrence rate than patients 
whose nodal disease had been contained within the 
capsule. Physicians began to treat patients with 
extracapsular disease with preoperative radiation 
3 6 
therapy. The rationale for preoperative 
radiation therapy in nodal disease is to kill tumor 
cells and diminish their ability to implant in the 
surgical field or metastasize below the clavicle. 
Treatment of nodal metastasis with radiation 
therapy has been a common practice for over 50 years. 
The radiation field extends from the 
mandible to the clavicle and from the 
midline anteriorly to the line of the 
transverse cervical processes posteriorly. 
The tissues of the neck should be adequately 
irradiated to a depth of 3 cm, but treatment 
is individualized according to need . . . 
The primary tumor must be adequately 
encompassed, and if it crosses the midline 
then the cervical lymph nodes on both sides 
of the neck should be irradiated. In 
general, higher doses of radiation are 
required to destroy gross tumor whereas 
smaller doses will eliminate the better 
oxygenated occult micrometastases, Kagan, p. 
235. 
Tumors of the floor of the mouth, tonsillar 
fossa, and anterior two-thirds of the tongue are 

Figure 15.1 
The main chains of lymph nodes in the neck. 
Group 1 includes the submental and submaxillary 
nodes; groups 2, 3, and 4 the upper, middle, and 
lower deep cervical nodes; group 5 includes nodes 
in the posterior triangle of the neck. 
Kagan and Miles, Eds. Head and Neck Oncology, 
Controversies in Cancer Treatment, G.K. Hall 
Medical Publishers, 1981 
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easily visible and subject to detection of early T 
stage (Tl-2). These tumors have not had the time to 
develop significant metastasis, so the patients often 
present without clinically positive neck nodes (NO). 
In these patients, the primary tumor can be treated 
equally effectively with either radiation therapy or 
surgery. Treatment of the microscopic tumor cells 
invariable present in the lymph nodes is with 
radiation therapy in the range of 3,000-5,000 rads 
principally in the subdigastric and submaxillary 
regions (region 1 and 2, Figure 6a and 6b) which are 
31 
the first level to be involved. 
Primary lesions of the hypopharynx present at a 
much more advanced tumor stage (T3-T4) and with more 
advanced nodal disease. The rich lymphatic drainage 
of the region permits the early development of 
metastatic seeding to cervical nodes. Patients 
frequently present with clinically positive necks and 
require more aggressive treatment, usually in the 
form of combination therapy. Primary tumors are 
frequently surgically excised. The presence of 
clinically positive lymph nodes in regions 3 and 4 
(see Figure 6a and 6b) implies that microscopic 
malignant cells are present in region 1 and 2. It 
increases the likelihood of tumor cells in the 
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retropharyngeal area (region 5). 
Barkley et al. (1972) at M.D. Anderson Hospital 
reviewed 596 patients of whom 181 had hypopharyngea1 
tumors. Patients with nodal disease received a total 
laryngectomy with total or partial pharyngectomy and 
ipsilateral radical neck dissection. Patients 
received postoperative radiation therapy for the 
following indications: 
1) surgical resection incomplete 
2) cancer cells or in situ mucosal changes 
close to the surgical margin 
3) clear surgical margins, but primary disease 
extended outside the hypopharynx 
4) nodes were positive at multiple levels 
5) cancer had broken through the nodal capsule 
6) primary lesion was in the midline with a high 
probability of bilateral lymph node 
metastases.23- 
He concluded that for patients with hypopharyngeal 
tumors and clinically negative necks, elective 
irradiation of only the subdigastric and mid-jugular 
nodes is necessary if the primary tumor is treated 
with irradiation. In patients with clinically 
positive nodes, combined treatment is superior to 
2 8 
either modality alone. 
Schneider et al. (1975) studied 183 patients with 
positive lymph nodes from squamous cell carcinoma of 
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the oral cavity, oropharynx, supraglottic larynx, and 
hypopharyx. Radiation doses were grouped at three 
levels 5,500 rads, 6,500 rads, and greater than 6,500 
rads. Doses in the range of 6,500 rads to a single 
lymph node, 3 cm or less in diameter produced 90 
percent control. When a non fixed lymph node of at 
least 3 cm is present, or there are multiple 
clinically positive nodes, radiation therapy should 
19 
not be relied upon for control. Increased 
recurrence rates occur with positive nodes at 
multiple levels, with nodes in inferior jugular and 
posterior triangle areas, and with soft tissue 
inva si on. 
Ninety to ninety-five percent of recurrent neck 
disease is manifested within two years of initial 
21 2 2 
treatment. * Recurrent neck disease may develop 
from microscopic tumor cells located in lymphatic 
channels, from nodes incompletely removed during neck 
dissection, or by seeding from uncontrolled primary 
tumor. In hypopharyngeal tumors, the size of the 
primary tumor does not correlate with the presence of 
nodal metastasis as it does in patients with primary 
tumors of the oral cavity and oropharynx. 
There is evidence that the filtering and trapping 
efficiency of lymph nodes is decreased by several 
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factors associated with the presence and treatment of 
malignancy including tumor growth, inflammation, and 
fibrosis secondary to radiation.^ 
In 1975, Lindberg and Jesse reported on five-year 
follow-up of treatment of positive cervical lymph 
nodes in patients treated between 1954 and 1965. 
Eighty-six percent of patients had pyriform sinus 
primary tumors and were treated with total 
laryngectomy and ipsilateral radical neck 
dissection. In patients with pyriform sinus tumors, 
superior regional control was achieved with 
combination therapy (14 percent recurrence at five 
years), compared to surgery alone (30 percent). 
Combination therapy improved regional control, but 
did not improve five-year survival outcome due to the 
36 
increased incidence of distant metastatic disease. 
Byers (1985) reported on a retrospective study of 
the largest single institution experience with the 
modified neck dissection reported in the world 
literature. Nine hundred sixty-seven patients 
received 1,372 modified neck dissections (each side 
of the neck is counted separately) between January 
1970 and December 1979. The study included patients 
with primary tumors of the oral cavity, oropharynx, 
36 larynx, and hypoharynx. 
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Among all patients treated the recurrence rate 
was 7 percent with surgery alone, 9.5 percent with 
preoperative radiation therapy and 6.6 percent with 
postoperative radiation therapy. Seventy-two percent 
of patients with single or multiple nodes 3 cm or 
greater demonstrated pathologically positive or 
extracapsular disease. 
Distant metastasis occurred in 15.8 percent 
(143/967) of all patients. Among these patients 9.3 
percent received surgery alone, 27.5 percent received 
preoperative radiotherapy and 21.7 percent received 
postoperative radiotherapy. Patients with one 
clinically positive node over 3 cm had a 29.3 percent 
3 6 
incidence of distant metastasis. 
Distant metastasis correlated more strongly with 
staging of nodal disease (N), than of primary tumor 
(T), a finding also reported by Grandi et al. in 
38 
Italy. There was an inverse relationship of 
distant metastasis with above the clavicle 
recurrence. He surmises that patients selected for 
radiation therapy had worse locoregional disease. 
Achievement of improved locoregional control places 
the patients at greater risk for systemic disease. 
He also speculates on the role of perioperative 
radiation on the evolution of distant metastasis 
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either directly or through effect on a patient's 
36 immune system. 
Marks et al. (1985) did a pathologic study to 
determine the presence of occult tumor in patients 
with clinically negative necks. He found the 
greatest incidence of occult disease in patients with 
pyriform sinus tumors (47 percent). The risk of 
nodal recurrence for patients with clinically 
negative necks and without occult disease was 
determined to be 8 percent compared to 88 percent for 
patients with occult or clinically positive nodes. 
They recommend that the low risk of recurrence 
without occult disease indicates pathologic analysis 
of the neck dissection specimen for occult disease 
should be performed in order to determine suitability 
for radiation therapy. The finding of occult disease 
greatly increases the risk of nodal recurrence and 
30 
indicates the necessity for radiation therapy. 
In summary, the extent of cervical node 
involvement has been consistently demonstrated to 
have prognostic significance for recurrent local, 
regional, and distant metastatic disease. The 
clinically negative neck can be judiciously treated 
with radiation therapy. Single positive nodes 
greater than 3 cm in diameter can be most effectively 

controlled with modified neck dissection and 
postoperative radiation therapy. Positive nodes at 
multiple levels can also often be controlled with 
surgery and postoperative radiation, but there is a 
greater risk of distant metastatic disease. The 
increased rate of systemic disease (more apparent 
with increased locoregional control provided by 
combination therapy) accounts for failure to improve 
five-year survival rates. 
One author summarized location of distant 
metastatic disease including results found at autopsy 
as follows (Figure 7): 
Lung 60 percent (48) 
Mediastinum 38 percent (30) 
Liver 28 percent (22) 
Bone (Rib/Skeleton) (25) 
Other sites of distant metastases included brain, 
heart, pleura/chest wall, adrenal gland, kidney, 
3 9 
skeleton, and other abdominal sites. 

C Therapy 
The hypopharynx is situated in the throat, 
inaccessible to direct radiation exposure. The deep 
anatomic location of the pyriform sinus and the late 
stage of the tumor at presentation (T3 and T4) (23a, 
25a, la) led to the use of surgical ablation as a 
principle form of therapy for tumors in this region. 
Dissatisfaction with high failure rates measured by 
duration of disease-free survival and absolute 
survival led to attempts to improve success rates. 
Teams of radiation therapists and otolaryngologists 
provided combination therapy irradiating the primary 
tumor and metastasis to cervical lymph nodes prior to 
33, 40-44 
surgery. 
The theoretical rationale for preoperative 
radiation therapy is to devitalize tumor cells and 
diminish their ability to implant in the surgical 
field during handling at surgery, or metastasize 
below the clavicle. The goals of preoperative 
radiation therapy were to reduce the bulk of primary 
tumor to provide better surgical access and wider 
surgical margins, and to sterilize any subclinical 
disease in cervical lymph nodes and vesels. Planned 
preoperative radiation therapy in this region 
utilizes submaximal doses, usually 4,500 to 5,500 
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33,41,44 
rads. 
In some cases, the surgical treatment was only 
utilized after tumor recurrence, usually in the 
primary site or regional nodes. This "surgical 
salvage" followed radiation therapy in doses up to 
2 7 44 
7,000 rads utilized for attempted cure. * The 
reported time interval between radiation therapy and 
4 4 
surgery varied from six weeks to six months. 
Experience showed there were many problems with 
operating on radiated tissues. Tissue friability, 
decreased vascularity and increased morbidity and 
surgical complications led physicians to experiment 
with postoperative radiation therapy. 
Survival 
Byhardt’s review of the literature covering treatment 
experiences at several medical centers in the 1960s 
and 1970s showed no significant advantage in 
three-year NED survival between preoperative 
radiation therapy and surgery 42 percent (120/288) 
and surgery alone 42 percent (77/185). Both were 
superior to radiation therapy alone 21 percent 
(29/141). Surgery with postoperative radiation 
therapy had less accumulated experience at that time, 
but indicated a tendency toward an improved 

three-year survival rate of 69 percent (15/22). At 
five years, survival rates for preoperative radiation 
therapy and surgery, and postoperative radiation 
therapy, were grouped together at 31 percent, and 33 
percent. Radiation therapy alone had a dismal 
2 9 
survival rate of 11 percent. 
Wang (1972) reported on 152 patients treated with 
high-dose radiation therapy (7,000 rads) with planned 
surgical treatment if tumor did not show satisfactory 
regression by the time 4,500 rads had been 
delivered. "Satisfactory regression" was not 
defined. Laryngectomy was performed between six 
weeks and six months. His report did not specify 
whether patients early in the series who received the 
highest radiation doses were also treated with 
laryngectomy. His results were encouraging with 
three-year NED survival of 63 percent (39/62) for T3 
lesions and 33 percent 15/45 for T4 lesions with an 
4 4 
overall survival of 58 percent. 
Despite the optimism of early reports on 
preoperative radiation therapy and surgery, a 
consistent trend of improvement has failed to 
emerge. 
Reasons presented for the apparent failure of 
preoperative radiation therapy and surgery to improve 
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survival outcome have included: 1) obscuring of 
surgical margins by tissue changes induced by 
33 
radiation therapy and 2) decreased cellular 
immunity secondary to radiation. The effects of 
ionizing radiation on lymph nodes could compromise 
the body’s ability to deal with tumor emboli leading 
to increased rates of tumor recurrence both 
32 4 3 
locally and distantly. 
Recurrence in the primary site or neck is 
associated with increased morbidity and decreased 
quality of life due to difficulty with swallowing or 
breathing with the presence of a mass lesion. 
Patients are sometimes subjected to repeated surgical 
procedures in an effort to relieve tracheal stenosis 
or esophageal stricture. Combination therapy has 
been directed at achieving improved local and 
regional disease-free survival, even if absolute 
survival results remain discouraging. Literature on 
recurrence rates with nodal disease is discussed 
elsewhere. 
It is well established in the literature that 
80-95 percent of recurrence in the primary or 
2 7 
cervical nodes occurs within two years. In 
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Byhardt's* review, there was an 83 percent rate of 
recurrence at the primary site and 68 percent 
recurrence in the neck among patients receiving 
preoperative radiation therapy and surgery. Distant 
metastasis occurred 21 percent of the time. 
In the Kirchner study with fifty-five pyriform 
sinus tumors, 76 percent had local recurrence within 
40 
three years. 
Yates, who found that "positive surgical margins 
were not lethal in surgery alone patients as in those 
having combined therapy," concluded that "patients in 
the combined [therapy] groups are somehow rendered 
less capable of dealing with residual disease." He 
also focuses on the issue of compromised cellular 
immunity secondary to radiation. With regard to 
preoperative irradiation, he writes: 
Compromised immune responses at the time of 
tumor surgery could interfere with the 
body's ability to deal with tumor cell 
embolization and implantation whether it be 
lymphatic, intravascular, or in the surgical 
field. This could explain increased local 
recurrence with preoperative irradiation . ^ 
*Cachin - 19 7 5 Marks 1978 
Eisbac h - 1977 Ogura - 1970 
I noue - 1973 Sugerman - 1979 
Kirchner 
Lord 
- 1977 
- 1978 
Wang - 1972 

Strong (1978) In a prospective randomized 
study of 100 patients compared surgery alone 
with preoperative radiation therapy (2,000 rads) 
and surgery. Of fifteen patients who failed due 
to recurrent cancer in the combination therapy 
group, 27 percent had primary recurrence 
compared to 39 percent among surgery only 
patients. The recurrence rate for nodal disease 
was virtually the same in the two groups at 72 
percent for surgery alone and 73 percent for 
combined therapy. He found that preoperative 
therapy appeared to increase the incidence of 
distant metastasis when compared to surgery 
alone, although he found no significant 
difference between the two treatment groups when 
comparing nodal recurrence, or three-year 
4 3 
survival. It may be that low-dose radiation 
levels serve to stimulate the growth and spread 
of microscopic tumor foci. 
Strong reported an increased incidence of 
positive surgical margins with preoperative 
irradiation. Strong theorizes that the low dose 
preoperative radiation treatments (2,000 rads): 
. . . may in fact increase the potential for 
distant metastases, perhaps by producing a 
depression of the patient’s immunologic 
defenses, thereby allowing microscopic foci 
of tumor cells to flourish in distant 
regions of the body.^3 
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He speculates that a higher incidence of distant 
metastases would have been detected if all 
patients had been autopsied. 
Reports by Eisbach, Strong, and most recently 
Yates have reported a failure to show improved cure 
rates with preoperative radiation therapy and surgery 
when compared to surgery alone. Yates (1983) has 
found that surgery alone demonstrated better 
three-year and five-year survival results (65 percent 
and 56 percent) compared to preoperative radiation 
3 2 
therapy and surgery (50 percent and 36 percent). 
It should be noted that retrospective studies showing 
better results with surgery alone, Eisbach and Yates, 
involve small numbers of patients, 19 and 21 
respectively. 
In summary, despite some indication in Strong’s 
prospective study that preoperative radiation therapy 
may afford greater local control, the preponderance 
of retrospective data indicates no consistent 
advantage to preoperative radiation over surgery 
alone. In fact, there are indications that 
preoperative radiation may increase the rate of nodal 
and distant metastasis. 

S urgery_and_Pojtoperative_Radiation_Therapy 
Early surgical reconstructive techniques required 
staged procedures over several months and were 
fraught with high morbidity associated with multiple 
surgical procedures including infection and wound 
dehiscence. These reconstructions were also subject 
to unravel as a result of radiation therapy delivered 
postoperatively in excess of modest doses (>5,500 
rads). Improved reconstructive techniques have made 
it possible to deliver high-dose postoperative 
radiation (5,500 to 7,000 rads), beginning as soon as 
three weeks postoperative. The difficulties of 
operating on heavily irradiated tissues increased 
tissue friability, decreased vascularity, and 
increased incidence of wound infections. 
Survival 
Byhardt reported a 69 percent (15/22) survival at 
three years which fell to 36 percent (39/107) at five 
years. These were patients from an older series who 
received radiation therapy to the level of 4,500 
2 9 
rads. Yates reported a 50 percent (5/10) 
determinate two-year survival with no evidence of 
disease (NED), and a 25 percent five-year NED 
survival. Patients in his series received a minimum 

5 5 
of 4,500 rads.32 
Sasaki and Badawi both reported on patients who 
had received high-dose postoperative radiation (5,000 
to 7,000 rads). Badawi reported 50 percent (63) 
three-year NED survival and 40 percent (50) five-year 
2 8 
NED survival. Sasaki reported a figure for 
overall survival rate in patients followed-up from 
two to 15 years of 26 percent (13/50). Two-year NED 
survivals for Stage III patients were 45 percent and 
2 
for Stage IV patients 15 percent. 
Sasaki also characterized his survival rates by 
the number of nodes found to be histologically 
involved with tumor, 50 percent for zero to one node, 
31 percent for two to three nodes, and 16 percent for 
four or more nodes. He concluded that the number of 
involved nodes is the most important determinant of 
2 
NED survival. 
Badawi concluded that statistical differences in 
control above the clavicles and in five-year survival 
was in favor of planned combined treatment, and that 
failures of postoperative radiation increase with 
increasing time interval between the surgical 
procedure and the beginning of radiation therapy. He 
also characterized the causes of death between two 
and five years as due to intercurrent disease, 
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distant metastatic disease, and second primary 
28 
tumors. 
These two-year survival rates for postoperative 
radiation are considerably better than the 42 percent 
reported by Byhardt in his compilation of 
preoperative radiation series, but comparable to the 
two-year survival rates reported by Yates (50 
percent) for surgery alone and three-year survival 
reported by Wang (63 percent) for preoperative 
radiation. The five-year survival rates for 
postoperative radiation reported by Byhardt (36 
percent) is comparable to the 40 percent achieved by 
Badawi with high-dose postoperative radiation. Yates 
reports only 25 percent five-year survival while 
Sasaki's 26 percent follow-up figure includes 
patients followed up to 15 years for "overall cure.” 
Byhardt's five-year survival for preoperative 
radiation falls right between these figures at 31 
percent. Yates found a similar five-year survival 
rate of 36 percent for preoperative radiation and 
none of these five-year results match the 56 percent 
survival he found in the surgery alone arm of his 
study. 

Recurrence 
Byhardt reported a discouraging 83 percent local 
and 68 percent regional recurrence rate in his 
compilation from nine authors. The reports of 
subsequent authors are more encouraging Yates (10 
percent), Badawi (11 percent), and Sasaki (32 
percent) for regional recurrence, for Yates and 
Sasaki respectively. 
In summary, the results of the articles reviewed 
here indicate that postoperative radiation improves 
locoregional control. Although there appears to be 
tendency toward improved two-year and five-year 
survival rates, this is not a consistent finding. 
The best two-year survival has been reported with 
postoperative radiation (Byhardt 69 percent), 
although Wang reported 63 percent with preoperative 
radiation. The best five-year survival has been 
reported with surgery alone (Yates 56 percent). The 
best five-year survival reported for combination 
therapy was with postoperative radiation (Badawi 40 
percent). Five-year survival rates for preoperative 
radiation therapy were all grouped around thirty 
percent. Among articles reviewed here, five-year 
survivals for postoperative radiation and surgery 
were in two groups one between 35-40 percent and the 

58 
other around 25 percent. 
Current retrospective reports focus on different 
details of specific aspects of clinical presentation 
to determine prognosis, e.g. the presence of 
clinically positive lymph nodes at multiple levels in 
the neck, rather than just the total number of nodes 
as reported by earlier authors. More specific 
aspects of treatment and outcome are also being 
scrutinized and reported on, e.g. the presence or 
absence of positive margins at the time of surgical 
resection, the time interval between surgery and 
radiation therapy, the presence or absence of 
histologically positive lymph nodes in the specimen, 
and the specific sites of recurrences. In this way, 
surgeons hope to provide an improved quality of 
survival for patients with a disease in which 
survival outcome has not been affected by all 
treatment efforts to date. There are few 
retrospective reports which include all this data 
because it is often inconsistently reported in 
patients’ charts. 
Retrospective studies which utilize consecutive 
series of patients have been criticized as obscuring 
patient selection bias which develops over time. 
Accumulated surgical experience evolves more specific 
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criteria for utilization of particular treatment 
methods. There is a natural tendency to improve 
• , u , , . 25,28 
surgical therapy and technique over time. 
Other authors defend these studies as reasonable 
because the nature of ablative surgery has not 
fundamentally changed over time, although more 
emphasis has been placed on reconstructive aspects 
with an increased tendency toward conservation 
surgery in more recent years. 
Prospective randomized studies would have to be 
very lengthy to accumulate adequate numbers of 
patients with this uncommon tumor. Alternatively, 
multi-center prospective randomized studies include 
larger numbers of patients in a shorter time, but are 
costly, and difficult to organize. Retrospective 
studies provide a convenient method for summarizing 
and analyzing the accumulated experience of a 
specific medical center, although the results should 
2 4 be reviewed and evaluated cautiously. 
Pro tidies 
In 1977, Vandebrouck reported on a prospective 
randomized trial of preoperative radiation therapy 
and surgery versus surgery and postoperative 
radiation. He found a 56 percent five-year survival 
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with postoperative radiation compared to a 20 percent 
five-year survival with preoperative radiation (some 
patients received high doses to 7,000 rads). His 
study was discontinued after 49 patients due to the 
high rate of perioperative mortality caused by 
hemorrhage (38 percent from the carotid artery) in 
the preoperative radiation therapy group. ^ 
In 1981, Snow published his second preliminary 
report on a prospective, randomized, raulticenter 
trial comparing preoperative radiation therapy and 
surgery with postoperative radiation therapy. This 
study included patients with lesions of the oral 
cavity, oropharynx, and hypopharynx, although results 
are reported separately by region. Two-year survival 
rates for all sites are 54 percent for preoperative 
radiation. The estimated two-year survival rates for 
hypopharyngeal tumors is 42 percent for postoperative 
radiation and 38 percent for preoperative radiation. 
The locoregional recurrence rate was 26 percent for 
preoperative radiation and 16 percent for 
4 7 postoperative radiation. Although survival rates 
were not significantly different, there was a trend 
in favor of postoperative radiation therapy. 
Postoperative radiation showed a clear advantage over 
preoperative radiation in locoregional control. He 
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found disease stage at presentation is a significant 
prognostic factor for survival in patients with 
lesions of the hypopharynx as well as oropharynx and 
supraglottic larynx. Disease stage was not a 
significant factor affecting locoregional control, 
although apparently sequence of therapy is. His 
results for two-year survival show little advantage 
of either sequence of combination therapy, although 
both are considerably lower than the best results 
reported in retrospective series discussed earlier. 

MATERIALS AND METHODS 
Patient_Population 
This study covered the years from January 1963 
through the end of December 1984. All patients were 
treated with radiation therapy and surgery for tumors 
of the pyriform sinus and hypopharynx by the Yale 
Section of Otolaryngology and the Yale Department of 
Radiation Therapy. Patients were identified through 
the Tumor Registry of Yale-New Haven Hospital. 
Eighty-six patients were reviewed who were 
planned to receive combination therapy. Fifty-nine 
were excluded who received salvage therapy or where 
there was recurence prior to initiation of second 
mode of treatment. Six patients were excluded who 
had early stage lesions (Stage I or Stage II). The 
remaining patients (17) were excluded whose follow-up 
records were incomplete regarding date of diagnosis, 
dates of treatment, or without a minimum of two years 

f ollow-up . 
The population includes patients treated at the 
West Haven Veteran's Administration Hospital and the 
private and community services of the Yale-New Haven 
Hospital. Patient records were reviewed for prior 
smoking history, prior drinking history, presenting 
symptoms, physical exam of primary tumor and cervical 
nodes, date of biopsy diagnosis, pretreatment 
staging, treatment plan, surgical complications, 
surgical pathology and follow-up to recurrence, 
metastasis, and/or death. Record review was done by 
the author at the Medical Records Departments of the 
Yale-New Haven Hospital, the West Haven Veteran's 
Administration Hospital, and the clinic records of 
the Yale Section of Otolaryngology. Follow-up was 
also conducted at the Yale Tumor Registry. Where 
possible patient's families were directly contacted. 
Demographics of the patient series reviewed is 
consistent with that reported by authors in the 
literature. The mean age was 61.6 years. 
Ninety-five percent of the patients were Caucasian 
(there were three Afro-Americans). Eighty-five 
percent of the patients were male. The longest 
patient follow-up was 20 years, 8 months in the 
preoperative radiation group. Both groups had 

several patients surviving nine years. 
Clinical staging by the TNM classification was 
determined by the clinician at the time of 
treatment. All patients included in the study had 
advanced disease (Stage III and IV), which includes 
patients with any clinical nodal disease at primary 
tumor stage T1 or T2 as well as any primary T3 or 
greater. See Table 1. 
The two-year and five-year survival data was 
evaluated using the chi-square method for analysis of 
significance. The mean survival difference was 
evaluated using the student's t test on the geometric 
mean. 
Table 1 Clinical Staging of Tumors 
Preoperative Radiation 
N o 
N1 
N 2 
N3 
T1 T2 T3 T 4 
3 4 
12 2 2 
2 4 
2 3 3 
Postoperative Radiation 
N o 
N1 
N 2 
N3 
T1 T2 T3 T 4 
3 4 
3 3 4 3 
2 4 
2 3 3 
All diagnoses were histologically confirmed by 
biopsy or surgical pathology specimen. All patients 
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were diagnosed with squamous cell carcinoma. The 
distribution of histologic classification is shown in 
Table 2. 
Table 2 Histologic Classification of Tumors 
Pr e £P£££££X£_^£^£££:i:2£_if£££P 
Poorly Moderately Well 
Differentiated Differentiated Differentiated Total 
9 5 14 28 
Z££££P£££££££_^£^£££l££_^£°£P 
Poorly Moderately Well 
Differentiated Differentiated Differentiated Total 
9 11 10 30 
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Treatment 
In the preoperative radiation therapy group, 
radiation was delivered in the low (-4,000 rads), 
moderate (4,000-5,500 rads), and high (5,500-7,000) 
dose ranges (see Table 3). Among the 29 patients in 
the preoperative radiation therapy group, 59 percent 
(17) received moderate dose (4,000-5,500 rads), for 
most of these the dose was 4,500 rads or less. 
Surgical treatment consisted of total laryngectomy in 
all cases except one. Radical neck dissections were 
performed in all cases except three. There were two 
functional neck dissections and one supraonohyoid 
dissection. 
In the postoperative radiation therapy group, 
radiation was delivered in the moderate and high dose 
ranges (see Table 3). Among the 30 patients in the 
postoperative radiation therapy group, 53 percent 
(16) received high-dose radiation (5,500-7,000 
rads). Surgical treatment consisted of total 
laryngectomy in all cases. Nodal disease was treated 
with radical neck dissection in 70 percent of 
patients (21/30). Eight patients received functional 
neck dissections and there was one modified neck 
dissection. 
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Table 3 Radiation Therapy Doses 
Pr e££££££ iv£ Rad iat i on_Therapy_Gr oup 
Thousands 
of Rads 3 3.5 4 4.5 5 5.5 6 6.5 7 Total 
? of Pts 3 11 - 3 - 3 1 4 29 
Z££££P££££i££_^£^£££A££_2-^£££ PZ_^£££P 
Thou sa nd s 
of Rads 3 3.5 4 4.5 5 5.5 6 6.5 7 Total 
? of Pts 3384921 30 
The mean time interval between therapeutic modes 
in the preoperative radiation therapy group was 67.5 
weeks. In the postoperative radiation therapy group, 
the time interval between therapeutic modes was 
planned to be as close to three weeks as possible. 
The mean interval in the postoperative radiation 
group was five to six weeks. Correcting for one 
patient whose planned four-week interval was extended 
to 16 weeks due to surgical complications, the mean 
interval was four to seven weeks. Table 4 shows the 
time intervals in both groups. 
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Table 4 Time Interval Between Therapeutic Modes 
Pr e PPPPPAAPP-APAAPAAPP-AP .21!P 
Number of Weeks 2 4_6_8_10_12_AP£PA 
Number of Patients 1896 3 2 29 
AP2£PP2PP£A£P_APAA.P£APP_.APPPP 
Number of Weeks 2 3 4 5 6 7 8_9_10_1^_14_16_Tota 1 
Number of Patients 296353 1 129 
Disease-free survival was determined as time from 
completion of initial mode of therapy (whether 
radiation or surgery) to documented date of tumor 
recurrence, death of the patient, or date last seen. 
Recurrent tumor was evaluated based on clinical 
behavior of growths in primary site and in the neck, 
and in most cases was confirmed by biopsy. Second 
primary tumors reported in the chart by the clinician 
present are accepted as such and not considered 
recurrence s. 

RESULTS 
Both patient groups were comparable regarding 
staging of primary tumor and nodal disease (see Table 
1). The most common presenting symptoms were 
hoarseness (77 percent), difficult or painful 
swallowing (47 percent), mass in the neck (40 
percent). Other frequently reported symptoms 
included excess weight loss (30 percent), sore throat 
(23 percent), and ear pain (25 percent). Symptoms 
that were rarely reported included shortness of 
breath, persistent cough, hemoptysis, and stridor. 
Seventy-one percent of patients were documented 
as heavy smokers, 64 percent were documented as heavy 
drinkers. There were a number of patients whose 
smoking and drinking habits could not be documented 
because patient records had been consolidated for 
storage purposes. 
Two patients in the preoperative radiation 
therapy group died in the perioperative period from 
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exsanguination due to carotid rupture. Fifty-two 
percent of patients (15/29) died in less than one 
year. The mean survival time was 42.4 months. The 
two-year NED survival was 45 percent (13/29), the 
five-year survival was 24 percent (7/29). 
Among patients receiving postoperative radiation 
therapy and surgery, the mean survival time was 26.7 
months. Forty-seven percent (14/30) of postoperative 
therapy patients died in less than one year. The 
two-year NED survival was 37 percent (11/30). The 
five-year NED survival was 17 percent (5/30). These 
results are shown in Table 5. 
Table 6 shows the duration of disease-free 
survival by tumor stage. The difference in survival 
under different treatment groups did not achieve 
significance using the chi-square method. 
Table 5 NED Survival (Percent) 
Two-Year Five-Year 
Pre-Op 
Po st-Op 
45 (13/29) 
37 (11/30) 
24(7/29) 
17 (5/30) 
Table 6 Survival by Tumor Stage (Percent) 
Two-Year Five-Year 
Pre-Op 
Stage III 
Stage IV 
5 
8 
3 
4 
Po st-Op 
Stage III 
Stage IV 
3 
8 
1 
4 
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Patients in a number of cases died of 
intercurrent disease related to the ravages of their 
lifestyle and not due to the initial malignancy. 
Some of these causes were cirrhotic liver disease, 
diabetic renal disease, and suicide. Some patients 
died of causes secondary to treatment induced 
changes—these included airway obstruction and 
respiratory arrest, secondary primary tumor, and 
aspiration pneumonia. 
Among patients in the preoperative radiation 
therapy group recurrence and/or distant metastasis 
were documented in 45 percent of patients (13/29). 
Two patients had both recurrent and metastatic 
disease. Nine recurrences occurred in local or 
regional sites (31 percent). There were six patients 
with documented distant metastasis (20 percent). 
Sites of distant metastasis included lung (4), liver 
(1), and renal (1). 
In the postoperative radiation therapy group, 
recurrence and/or distant metastasis was documented 
in 13 patients (43 percent). One patient had both 
recurrent and metastatic disease. Six patients had 
local or regional recurrences (20 percent). There 
were eight patients with documented distant 
metastasis (26 percent). Sites of distant metastasis 
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included lung (4), liver (2), and bone (2). 
The surgical complication rate in the 
preoperative radiation therapy group was 30 percent 
(9/30). This includes two perioperative 
mortalities. There were three fistulas, three lung 
infiltrates and one wound abscess. The surgical 
complication rate in the postoperative radiation 
therapy group was 28 percent (8/29). There were 
three fistulas, two aspiration pneumonias, two wound 
infections, and one pulmonary infiltrate. 

DISCUSSION 
Several factors make it difficult to draw 
significant conclusions from this study. It is a 
retrospective study using historical controls. The 
limitations of retrospective studies are discussed 
earlier. The large number of patients lost to 
follow-up, 17 (19 percent of patients reviewed), 
further weakens our ability to draw significant 
conclusions from this data. 
The patient groups included similar numbers and 
were comparable based on tumor staging, surgical 
treatment and dose of radiation therapy received. 
Preoperative radiation therapy and surgery was 
demonstrated to provide a slightly higher rate of 
two-year and five-year survival, although these 
results are not statistically significant. These 
results disproved my hypothesis. 
One reason the postoperative radiation therapy 
group did not have a better outcome may be that many 

patients in this group (47 percent) received 
submaxiraal radiation doses of 5,500 rads or less. 
The maximum therapeutic dose in the head and neck 
region is 7,000 rads. 
My literature review showed no clear consensus 
has emerged regarding the most effective form of 
treatment for these desperate patients. Although 
encouraging five-year survival results have been 
reported by individual authors for surgery alone, 
preoperative radiation therapy, and postoperative 
radiation therapy, other authors have not reproduced 
these results. The most definitive study in the 
literature, the randomized multicenter study reported 
by Snow, found that preoperative radiation therapy 
and surgery was equivalent to surgery and 
postoprative radiation therapy. The recurrence and 
survival results in the two treatment groups reported 
here are also equivalent. 
It is clear that patients diagnosed with advanced 
stage squamous cell carcinoma of the pyriform sinus 
and hypopharynx have a disease with an extremely 
grave prognosis which is essentially using any 
current form of treatment. Perhaps some inroads can 
be made with immunotherapy using activated 
lymphocytes or using triple therapy combining 

surgery, radiation, and chemotherapy. Greater 
control of the disease may also be achieved through 
screening and early detection of high risk patients. 
The two perioperative mortalities due to carotid 
rupture in the preoperative radiation therapy group 
are cause for concern. Postoperative radiation 
therapy seems to carry less risk of perioperative 
mortality and should be utilized for its practiced 
advantage if other risk factors are equal. 

APPENDIX A 
TYPES OF MODIFIED NECK DISSECTION 

APPENDIX A 
VARIATIONS 
NAME 
SUPRAHYOID 
SUPRAOMOHYOID 
ANTERIOR 
POSTERIOR 
LOWER 
FUNCTIONAL 
OF THE MODIFIED NECK DISSECTION* 
DISSECTED NODAL GROUPS 
Submental and submaxilla 
Submental, submaxillary, 
subdigastric, upper 
posterior cervical, mid¬ 
jugular 
Subdigastric, midjugular 
lower jugular 
Upper, middle, lower 
posterior cervical 
Lower posterior cervical 
supraclavicular, lower 
jugular 
Submental, submaxillary, 
subdigastric, midjugular 
lower jugular, and upper 
middle, lower posterior 
cervical 
*From Byers, 1985. 
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